Indication
Alpha Thalassemia Hemoglobin H Constant Spring
1 clinical trial
1 product
Clinical trial
Study to Evaluate the Safety and Efficacy of RM-004 Cells for the Treatment of Hemoglobin H-Constant Spring DiseaseStatus: Recruiting, Estimated PCD: 2025-10-31
Product
RM-004